The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
4.5. President’s guests & roundtable meetings – members’ meeting
Return to January 2016 Board Agenda here.
a) President’s Guests
At the time of writing the following organisations have accepted invitations to be represented at the Congress:
- American Society of Health System Pharmacists, ASHP (C. Jolensky, Immediate Past President; Paul Abramowitz
- Pharmaceutical Group of the European Union, PGEU (Ilko Getov, PGEU Vice-President – also a CTF WG1 member)
- European Pharmaceutical Students Association, EPSA (Katarzyna Swiderek, President)
- European Society of Clinical Pharmacy, ESCP (Markus Lampert, President)
- European Medicines Agency, EMA (Nathalie Bere, Patient Relations Coordinater)
- European Association of Pharmacy Technicians, EAPT (Joao Jose Joaquim, President)
- European Generic and Biosimilars Medicines Association, EGA (Pieter Dylst, EGA Hospital Markets Group)
- European Directorate for the Quality of Medicines and Healthcare, EDQM (Silvia Ravera, Scientific Officer)
- Pharmaceutical Care Network of Europe, PCNE (Eline Vandael, UZ Leuven)
- European Industrial Pharmacists Group, EIPG (Claude Farrugia, VP Communications)
- European Society of Oncology Pharmacy, ESOP (Marika Saar)
- European Public Health Alliance, EPHA (Sascha Marshang, Health Systems Policy Manager)
- European Nurse Directors Association, ENDA (Iris Meyenburg Altwarg, President)
- European Oncology Nursing Society, EONS (Dr Andreas Charalambous, Board Member)
Full RSVP list here.
Meetings to be scheduled.
b) Members’ Meeting
The Members meeting will focus on two issues in particular: the Common Training Framework and the Falsified Medicines Directive. Andreas Walter, Director General of EMVO, has agreed to present on the current status of FMD implementation issues.
The meeting takes place on Tuesday 15th March from 1300 to 1730 in the OE Forum.
The current RSVP list is here.
Detailed agenda and background documents to be sent to Presidents and Delegates in coming weeks.